PCOS vs Cushing: Hormonal Differences, Symptoms, and Management

PCOS and Cushing’s syndrome are two distinct hormonal conditions driven by different biochemical engines, yet they look remarkably alike on the surface. PCOS is fundamentally an androgen-excess disorder rooted in ovarian dysfunction and insulin resistance, while Cushing’s syndrome is a cortisol-excess disorder caused by prolonged exposure to abnormally high glucocorticoid levels. The overlap in visible symptoms, particularly excess hair growth, irregular periods, and weight gain, is wide enough that half of reproductive-age women ultimately diagnosed with Cushing’s disease had initially been diagnosed with and treated solely for PCOS.¹ Understanding what separates them matters because their treatments, risks, and long-term trajectories are fundamentally different.

Why These Two Conditions Get Confused

Both PCOS and Cushing’s syndrome can cause hirsutism (excess body and facial hair), acne, menstrual irregularities, central weight gain, and difficulty getting pregnant. From the outside, a woman with either condition can look strikingly similar to a clinician seeing her for the first time. One review of the overlap emphasized that Cushing’s syndrome is “remarkably prevalent among young females” and can present with menstrual irregularities and signs of excess androgens, all features shared with PCOS.² Because PCOS is far more common, affecting roughly four to six percent of reproductive-age women, it is naturally where clinicians’ minds go first.³ Cushing’s syndrome, by contrast, is rare, and that rarity works against patients who have it.

The confusion goes beyond symptom lists. In a study of 50 patients with pathologically confirmed Cushing’s disease, 26 were women of reproductive age. Of those 26, half had been previously diagnosed with and treated exclusively for PCOS. Hirsutism and menstrual abnormalities were actually more common in the group initially mislabeled as PCOS than in those correctly identified with Cushing’s from the start.¹ This suggests that the patients whose Cushing’s looks most like PCOS are exactly the ones most likely to be missed.

What Is Actually Going Wrong Hormonally

Despite the surface similarity, the hormonal machinery behind each condition is quite different. In PCOS, the core problem centers on the ovaries and on insulin. The ovaries overproduce androgens like testosterone, driven in part by abnormal signaling from the brain’s hormonal control center. Increased pulses of gonadotrophin-releasing hormone lead to excess luteinizing hormone, which in turn ramps up ovarian androgen production and disrupts normal egg development.⁴ Insulin resistance amplifies the problem: when cells stop responding well to insulin, the body pumps out more of it, and that extra insulin pushes the ovaries to make even more androgens. Roughly half to seventy percent of women with PCOS have some degree of insulin resistance.³

In Cushing’s syndrome, the problem is cortisol. Either the adrenal glands are overproducing it (from a tumor on the gland itself) or the pituitary gland is overproducing ACTH, the hormone that tells the adrenals to make cortisol. In Cushing’s disease specifically, a pituitary tumor is the trigger. The sustained flood of cortisol causes its own kind of hormonal chaos: it suppresses the brain’s reproductive signaling, leading to low levels of luteinizing hormone, follicle-stimulating hormone, and estrogen. A case report of a 33-year-old woman initially treated for PCOS for two years illustrated this pattern; after stopping birth control pills, her bloodwork revealed central hypogonadism caused by high cortisol suppressing her reproductive hormones from the top down.⁵ The adrenals also make androgens, so Cushing’s can produce hirsutism and acne through a different pathway than PCOS.

This distinction matters practically. In PCOS, the androgens are primarily ovarian in origin; in Cushing’s, the androgen excess is a downstream effect of cortisol overproduction. The adrenal contribution to androgen levels in PCOS exists but is less well defined, which is part of why the two conditions can blur together in lab results.⁴

Physical Signs That Point One Way or the Other

Once you know where to look, the two conditions do produce some physically distinct patterns, even though a first glance can be misleading. PCOS tends to cause weight gain and fat accumulation in a central pattern, with higher amounts of visceral and trunk fat compared to women of similar body weight without PCOS.⁶ But the fat distribution in PCOS generally looks like a more exaggerated version of typical central obesity.

Cushing’s syndrome, on the other hand, produces a distinctive redistribution of fat that tends to look different from ordinary weight gain. Fat deposits between the shoulder blades (sometimes called a “buffalo hump”), a round and full face (“moon face”), and fat accumulation behind the collarbones are more specific to cortisol excess than to androgen excess. Cushing’s also causes thin, fragile skin that bruises easily, wide purple-red stretch marks on the abdomen or thighs, and proximal muscle weakness, meaning the large muscles of the hips and shoulders get noticeably weaker. These features are uncommon in PCOS.

Hirsutism and acne appear in both conditions, and on their own they don’t help distinguish one from the other. But when hirsutism appears alongside any of Cushing’s distinctive physical signs, the clinical picture shifts. Screening for underlying conditions that mimic PCOS, including Cushing’s syndrome, congenital adrenal hyperplasia, and androgen-producing tumors, is a standard step in confirming a PCOS diagnosis.⁷

How Doctors Tell Them Apart

The diagnostic workup for PCOS and Cushing’s involves different tests targeting different hormones. For PCOS, the standard approach includes measuring serum total testosterone, DHEA sulfate (an adrenal androgen), and 17-hydroxyprogesterone to rule out congenital adrenal hyperplasia.⁸ When the 17-hydroxyprogesterone level is unclear, a stimulation test using ACTH can help separate PCOS from adrenal hyperplasia.⁷ Ultrasound looking for polycystic ovarian morphology rounds out the PCOS assessment, though not all women with PCOS have visible ovarian cysts and not all women with visible cysts have PCOS.

To screen for Cushing’s, the workup targets cortisol levels from different angles. The three main screening tools are the overnight dexamethasone suppression test, 24-hour urinary free cortisol, and late-night salivary cortisol. Each has strengths and blind spots. In a study screening obese women with and without PCOS, the one-milligram dexamethasone suppression test showed the greatest specificity and diagnostic accuracy for differentiating Cushing’s from PCOS and simple obesity. Midnight plasma cortisol performed similarly, while urinary free cortisol could give misleadingly elevated results in women with PCOS.⁹ This is a practical point: if your doctor orders only a urine cortisol test and you have PCOS, a borderline result could cause confusion.

Late-night salivary cortisol has also proven reliable for PCOS patients. Research shows that the test is unaffected by PCOS or obesity, making it a trustworthy screening option in exactly the population most likely to be confused with Cushing’s.¹⁰ The catch is that no single test rules out mild Cushing’s syndrome definitively. Neither a normal urinary cortisol nor a normal late-night salivary cortisol alone can exclude mild cases, so multiple tests and sometimes repeat testing are needed.¹¹

Treatment Looks Completely Different

This is where the paths sharply diverge. PCOS management is typically medical and lifestyle-based, aiming to manage symptoms and reduce long-term metabolic risks. Combined oral contraceptive pills are often the first-line treatment to regulate periods, suppress androgen production, and manage acne and hirsutism. Metformin is used to address insulin resistance. A systematic review and meta-analysis found that when it comes to hirsutism specifically, there was no clear difference between metformin and combined oral contraceptive pills, nor between the pill alone and the pill combined with metformin.¹² Anti-androgen medications like spironolactone are another option. When anti-androgens were combined with lifestyle changes, they outperformed metformin plus lifestyle changes for hirsutism and for markers of insulin sensitivity, though they weren’t better than placebo plus lifestyle changes for hirsutism on its own.¹³ Lifestyle modifications, especially weight loss, remain a cornerstone of PCOS treatment because they can improve insulin sensitivity and reduce androgen levels.

Cushing’s syndrome treatment targets the cortisol source directly. When a pituitary tumor is responsible (Cushing’s disease), the first-line treatment is surgery to remove that tumor. Pituitary surgery leads to remission in about 78 percent of patients, but roughly 13 percent relapse within ten years. That means nearly a third of patients eventually need additional treatment.¹⁴ Second-line options include pituitary radiation therapy, which controls cortisol in a large proportion of patients but carries a substantial risk of damaging the pituitary’s other hormone production. Surgical removal of the adrenal glands (bilateral adrenalectomy) controls cortisol quickly and definitively but leaves the patient permanently dependent on replacement hormones. Medical therapy, including newer drugs that block cortisol production or its effects, has become more important as additional compounds have reached the market.

The fundamental difference in management philosophy is clear: PCOS treatment is chronic and symptom-focused, usually lasting years or decades. Cushing’s treatment aims for a cure by eliminating the tumor or excess cortisol production, though follow-up is lifelong because relapse and hormonal deficiencies after surgery are real concerns.

Mental Health Consequences

Both conditions carry a significant mental health burden, though the mechanisms and timelines differ. PCOS is associated with higher rates of anxiety and depression, driven in part by the visible symptoms (hirsutism, acne, weight gain), by hormonal effects on mood, and by the distress of infertility and chronic disease management.

Cushing’s syndrome hits mental health from a different angle: cortisol is directly neurotoxic at high levels and disrupts brain circuits involved in mood regulation. A large nationwide matched-cohort study found that patients with Cushing’s syndrome had nearly twice the odds of receiving antidepressant or anxiolytic medications compared to matched controls. Women were especially affected, with roughly 13 percent receiving such prescriptions compared to about 7 percent of controls. The risk of developing a new need for these medications was more than twofold higher in Cushing’s patients. Strikingly, even patients who achieved remission continued to have about twice the risk of needing mood-related medication during long-term follow-up, suggesting lasting effects on the brain.¹⁵ This persistence after cortisol normalizes is one of the more sobering findings in Cushing’s research, and it means that successfully treating the cortisol excess does not automatically resolve the psychiatric effects.

Pregnancy Risks in Each Condition

Both conditions complicate pregnancy, but in different ways. A comparative study of pregnancy and neonatal outcomes found that PCOS increased the likelihood of gestational diabetes and cesarean delivery compared to Cushing’s. Women with PCOS had roughly two-and-a-half-fold higher odds of gestational diabetes and similar odds of cesarean section compared to women with Cushing’s syndrome. On the other hand, Cushing’s syndrome was associated with higher rates of operative vaginal delivery and blood transfusion.¹⁶ No significant differences were found between the two for pregnancy-induced hypertension, gestational hypertension, or preeclampsia.

For women with PCOS, the fertility challenge often centers on irregular or absent ovulation. Treatments like letrozole or clomiphene can induce ovulation, and many women with PCOS conceive with medical support. For women with active Cushing’s syndrome, pregnancy is riskier and rarer, because chronically elevated cortisol suppresses reproductive function at the brain level. Most clinicians recommend controlling the cortisol excess before attempting pregnancy. Both groups benefit from closer monitoring during pregnancy than the general population.

Cardiovascular and Metabolic Risks

PCOS is strongly linked to metabolic syndrome, a cluster of conditions including altered blood sugar, abnormal cholesterol levels, elevated blood pressure, and chronic low-grade inflammation. These factors collectively raise cardiovascular risk. Multiple studies have underscored the connection between PCOS and markers of vascular injury, including higher levels of inflammatory markers like C-reactive protein and changes in blood vessel function.¹⁷ Because PCOS is a chronic condition diagnosed in the teens or twenties and lasting through menopause and beyond, the cardiovascular risk accumulates over decades.

Cushing’s syndrome also increases cardiovascular risk, but more acutely. Prolonged cortisol excess raises blood pressure, promotes visceral fat accumulation, impairs glucose tolerance, and accelerates atherosclerosis. The risk is concentrated during the period of active disease, and successful treatment reduces but does not fully normalize cardiovascular markers. Patients who have been cured of Cushing’s still show higher rates of cardiovascular events for years afterward compared to the general population, mirroring the lasting psychiatric effects mentioned earlier.

When Cushing’s Hides in Plain Sight

One particularly treacherous form is cyclical Cushing’s syndrome, where cortisol levels fluctuate between normal and elevated. A patient may test normal during a quiet phase and abnormal during an active one. Case reports describe cyclical Cushing’s masquerading as PCOS for nearly a decade before being identified.¹⁸ The intermittent nature of the cortisol production means that screening tests can come back normal if they happen to be drawn during a low phase, giving false reassurance.

This is why endocrinologists sometimes emphasize the value of clinical suspicion over any single lab result. If a woman originally diagnosed with PCOS develops new symptoms more typical of cortisol excess, such as easy bruising, purple stretch marks, muscle weakness, or worsening glucose control despite treatment, repeat screening for Cushing’s is warranted. Some experts recommend that all screening for mild Cushing’s include multiple sample types and multiple timepoints, precisely because a single normal result does not exclude the diagnosis.¹¹

The Adolescent Diagnostic Challenge

Diagnosing either condition in teenagers adds another layer of difficulty. Androgen excess affects somewhere between 3 and 20 percent of adolescent girls. In girls who have started puberty, PCOS accounts for 20 to 40 percent of cases of excess androgens, making it the single most common cause, while congenital adrenal hyperplasia accounts for about 14 percent. Androgen-producing tumors are rare, at around 0.2 percent.¹⁹ Cushing’s syndrome is not even listed among the common causes in this age group, which reflects both its rarity and the risk that it may be overlooked.

Normal puberty itself raises androgen levels and can cause acne, irregular periods, and some degree of weight fluctuation, making it harder to tell pathology from normal development. The standard PCOS diagnostic criteria used in adults don’t translate cleanly to adolescents, because irregular periods and ovarian cysts are common in the first few years after a girl’s first period even in the absence of any disorder. Most guidelines recommend waiting at least two years after the first period before applying adult PCOS criteria, and confirming that elevated androgens persist beyond the normal pubertal window. If a teenager presents with severe or rapidly progressing symptoms, features atypical for PCOS like growth failure, or signs specific to cortisol excess, screening for Cushing’s and other non-PCOS causes of androgen excess should not be deferred by age alone.

The stakes of misdiagnosis in this age group are high. An adolescent put on oral contraceptive pills for presumed PCOS while actually harboring a cortisol-producing tumor could have the real diagnosis masked for years. Meanwhile, uncontrolled cortisol excess during adolescence can impair bone density accrual and linear growth at a time when both are critical. The takeaway for parents and young patients is that a PCOS diagnosis in a teenager should be made carefully, with appropriate exclusion of other causes, rather than assigned by default when irregular periods and acne appear together.